FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows the potentiation of its anticancer activity, and most remarkably, it improves the selectivity for cancer cells versus normal fibroblasts.
Molecular Weight:
822.6
CAS Number:
[1255143-82-8]
Formula:
C23H28F6IN4OsP
Target:
Others
T31899
T31899
* VAT and and shipping costs not included. Errors and price changes excepted
